Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong
· Delayed Price · Currency is HKD
99.05
-2.75 (-2.70%)
Last updated: Mar 10, 2026, 11:34 AM HKT
HKG:2659 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 46.66 | 6.16 | 6.93 |
| Revenue Growth (YoY) | - | -11.11% | - |
| Cost of Revenue | 0.95 | 1.14 | 0.15 |
| Gross Profit | 45.71 | 5.02 | 6.78 |
| Selling, General & Admin | 111.97 | 115.54 | 47.58 |
| Research & Development | 245.48 | 250.73 | 132.55 |
| Other Operating Expenses | -3.48 | -1.77 | -6.68 |
| Operating Expenses | 353.97 | 364.51 | 173.45 |
| Operating Income | -308.26 | -359.49 | -166.66 |
| Interest Expense | -5.22 | -4.56 | -3.66 |
| Interest & Investment Income | 6.44 | 4.65 | 7.9 |
| Earnings From Equity Investments | -0.48 | -0.61 | -0.92 |
| Currency Exchange Gain (Loss) | 0.44 | 1.19 | 2.97 |
| Other Non Operating Income (Expenses) | -18 | -5.57 | - |
| EBT Excluding Unusual Items | -325.08 | -364.38 | -160.37 |
| Gain (Loss) on Sale of Assets | -0.08 | -0.08 | -0.03 |
| Pretax Income | -380.24 | -364.46 | -160.4 |
| Income Tax Expense | - | -0.02 | -0 |
| Net Income | -380.24 | -364.43 | -160.4 |
| Net Income to Common | -380.24 | -364.43 | -160.4 |
| Shares Outstanding (Basic) | 56 | 54 | 51 |
| Shares Outstanding (Diluted) | 56 | 54 | 51 |
| Shares Change (YoY) | - | 5.82% | - |
| EPS (Basic) | -6.75 | -6.81 | -3.17 |
| EPS (Diluted) | -6.75 | -6.81 | -3.17 |
| Free Cash Flow | -248.81 | -338.06 | -276.58 |
| Free Cash Flow Per Share | -4.42 | -6.32 | -5.47 |
| Gross Margin | 97.95% | 81.49% | 97.85% |
| Operating Margin | -660.67% | -5835.80% | -2404.96% |
| Profit Margin | -814.93% | -5916.12% | -2314.50% |
| Free Cash Flow Margin | -533.26% | -5487.91% | -3991.02% |
| EBITDA | -277.6 | -329.76 | -146.12 |
| D&A For EBITDA | 30.66 | 29.73 | 20.55 |
| EBIT | -308.26 | -359.49 | -166.66 |
Source: S&P Capital IQ. Standard template.
Financial Sources.